Method for Reducing Levels of Disease Associated Proteins
First Claim
1. A method of reducing protein aggregation in the brain of a mammal, said method comprising administering a ketogenic treatment so to produce ketosis or a ketogenic state in the mammal for a predetermined period, whereby the protein aggregation is reduced.
5 Assignments
0 Petitions
Accused Products
Abstract
The subject invention concerns the reduction of protein aggregation in the neurons of a mammal through the use of a ketogenic treatment such as a ketogenic diet, a physical training regimen and/or administration of agents to increase fatty acid oxidation. Such ketogenic treatment can be useful in the reduction of certain aggregates including amyloid β peptide, polyglutamine containing huntintin protein, polyglutamine containing androgen receptor, polyglutamine containing atrophin-1, polyglutamine containing ataxins, α-synclein, prion protein, tau and superoxide dismutase 1 (SOD1).
-
Citations
20 Claims
- 1. A method of reducing protein aggregation in the brain of a mammal, said method comprising administering a ketogenic treatment so to produce ketosis or a ketogenic state in the mammal for a predetermined period, whereby the protein aggregation is reduced.
-
16. An assay for measuring the effectiveness of ketogenic treatment for the reduction or prevention of protein aggregation in cells, comprising
a) treating said cells in vivo or in vitro with a ketogenic treatment; - and
b) determining whether such treatment prevents or reduces protein aggregation in the cells. - View Dependent Claims (17, 18, 19, 20)
- and
Specification